What Elcam Drug Delivery Devices does

Elcam Drug Delivery Devices (E3D) is an Israel-based medical device manufacturer and wholly-owned subsidiary of Elcam Medical. The company develops, manufactures, and supplies injectable drug delivery devices, including disposable auto-injectors (Flexi-Q PFS, DV, PDVR, HV, EAI, CAI), reusable mechanical and electromechanical auto-injectors (Flexi-Q mMU, eMU-P, eMU-C), and wearable injectors and patch pumps (OBI-1, eLVD). E3D's products accommodate drugs in pre-filled syringes, vials, lyophilized vials, and cartridges across a viscosity and volume range, and incorporate proprietary features including a force-damping mechanism for high-viscosity biologics, RFID-based drug validation, passive needle safety, and wireless connectivity for adherence monitoring.

E3D operates a B2B business model selling to pharmaceutical company partners under long-term supply agreements tied to specific combination product filings, with the Flexi-Q PFS having been launched commercially in at least one blockbuster biologic combination product. The company also licenses its technology platforms, exemplified by a 2021 exclusive license to Jabil Healthcare for its mechanical multi-use auto-injector technology. The portfolio spans both standardized, off-the-shelf platforms for faster partner integration and extensively customized devices.

The company operates manufacturing sites across Israel (6,950 m²), Italy (4,000 m²), and the United States via a contract manufacturing partnership, with multiple ISO Class 8 clean rooms, ISO 13485 certification, and FDA 21 CFR Part 820 compliance. E3D leverages the 40-year medical device heritage of the Elcam group while maintaining a focused drug delivery specialization.

Name

Elcam Drug Delivery Devices

Legal name

E3D

Website

https://elcam3d.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Elcam Drug Delivery Devices (E3D) is an Israel-based subsidiary of Elcam Medical that designs, manufactures, and supplies injectable drug delivery devices—including disposable and reusable auto-injectors, wearable injectors, and patch pumps—for pharmaceutical company partners developing combination products with biologics and conventional drugs.

Ownership category

akta.pro rank

Product category

Drug Delivery Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Auto-Injectors (Disposable & Reusable) (HLAHAIAB)

akta.pro secondary industries

Wearable Injectors & On-Body Delivery Systems (HLAHAIAE), Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Injectable drug delivery
• Auto-injector devices
• Medical device manufacturing
• Prefilled syringe devices
• Wearable injector platforms

Headquarters

HQ city

Dovev

HQ country

Israel

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Drug Delivery Device Manufacturing and Supply: E3D manufactures and supplies auto-injectors and other drug delivery devices to pharmaceutical company partners for use with their drug products. Revenue is generated through device sales, typically under long-term supply agreements tied to specific drug/device combination products.
2. Technology Licensing: E3D licenses its proprietary device technology platforms to pharmaceutical partners, providing access to patented technologies such as the mechanical multi-use auto-injector technology under exclusive license agreements.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

E3D designs, develops, manufactures, and supplies a portfolio of injectable drug delivery devices—including disposable and reusable auto-injectors, patch pumps, and wearable injectors—for pharmaceutical companies seeking combination products for conventional, biological, and biosimilar drugs in vials, prefilled syringes, and cartridges. The company provides both standardized platforms for rapid market entry and customized device solutions, with end-to-end support from initial device design through regulatory approval to commercial supply.

Product overview

E3D (Elcam Drug Delivery Devices) offers a comprehensive portfolio of injectable drug delivery devices for self-administration in non-clinical environments. The product lineup includes: (1) Disposable Auto-Injector Platforms: Flexi-Q PFS (pre-filled syringes), Flexi-Q DV (drugs in vials), Flexi-Q PDVR (lyophilized drugs in vials), Flexi-Q HV (high viscosity drugs), Flexi-Q EAI (emergency use), and Flexi-Q CAI (chronic conditions); (2) Reusable Auto-Injector Platforms: Flexi-Q mMU (mechanical multi-use for PFS), Flexi-Q eMU-P (electromechanical for PFS with wireless connectivity), and Flexi-Q eMU-C (electromechanical for cartridges); (3) Wearable Injector Platforms: OBI-1 (bolus wearable injector) and eLVD Patch Pump (long-duration large volume delivery). All products support conventional drugs, biologics, and biosimilars, with customization available for pharmaceutical company partners.

Differentiator

Problem solved

Functional benefit

Products and services

• Flexi-Q PFS Single-use disposable auto-injector for drugs in pre-filled syringes (1mL), providing fully automated injection with button activation and passive needle safety. Used by pharmaceutical companies to differentiate drug products and support lifecycle management.
• Flexi-Q DV Disposable auto-injector for drugs in vials, providing user-friendly self-administration for vial-filled injectables with automated injection and safety needle shielding. FDA 510(k) cleared.
• Flexi-Q PDVR Disposable auto-injector for reconstitution and automated injection of lyophilized (freeze-dried) drugs in vials, providing fully-enclosed and simple drug preparation.
• Flexi-Q HV Single-use auto-injector for low to high viscosity liquid drugs in pre-filled syringes, incorporating a proprietary force-damping mechanism that protects glass PFS from mechanical damage while enabling use of high spring force for viscous drugs.
• Flexi-Q EAI 2-step disposable auto-injector for emergency-use therapies, delivering 0.1-1.0mL (1mL PFS) or 0.1-2.25mL (2.25mL PFS). Robust design meeting stringent reliability requirements for emergency applications.
• Flexi-Q CAI 2-step disposable auto-injector platform for chronic therapies, configurable for 1mL or 2.25mL PFS, subcutaneous or intramuscular injection. Designed for patients with dexterity challenges.
• Flexi-Q mMU Reusable mechanical multi-use auto-injector combining a reusable device with a single-use cassette incorporating a pre-filled syringe. Reduces per-injection cost with minimal material for storage and disposal; supports cost-per-injection reduction up to 80% versus disposable auto-injectors.
• Flexi-Q eMU-P Reusable electromechanical auto-injector with single-use cassette pre-loaded with PFS, featuring LCD screen, real-time guidance, wireless data transmission, RFID drug validation, and temperature sensor. Designed for long-term therapies requiring frequent injections.
• Flexi-Q eMU-C Electrical auto-injector with a reusable driving unit and disposable cartridge, compatible with biological drugs in cartridges for variable dosing. Features RFID technology for drug recognition, expiry checking, and safety.
• OBI-1 Wearable Injector Disposable bolus wearable injector for subcutaneous administration of biologic drugs, with automatic needle and soft cannula insertion, programmable delayed activation, compact size, and integrated safety features.
• eLVD (Patch Pump) Long-duration subcutaneous administration patch pump with a reusable driving unit and disposable unit. Compatible with biologics, features automatic needle/cannula insertion, and supports large volume delivery with pre-programmable injection profiles.

Quantifiable outcome

• Cost per injection reduced by up to 80% with reusable multi-use devices compared to disposable auto-injectors
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and flagship.

• Jabil HealthcarecoreOEM/ Whitelabel/ Licensing Partner · 4 March 2021Jabil Healthcare signed strategic collaboration agreement with E3D expanding pharmaceutical market offering. The agreement provides Jabil with exclusive license to develop drug delivery device product platform based on E3D mechanical multi-use auto-injector technology. This enables Jabil to offer E3D's proprietary technology within their pharmaceutical customer base.
• Elcam MedicalflagshipStrategic or Co-development PartnerE3D is a subsidiary of Elcam Medical, an Israel-based group with 40 years of experience in development, manufacturing and global distribution of medical devices. Elcam Medical provides corporate infrastructure, quality systems, and manufacturing expertise to support E3D's drug delivery device operations.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Ypsomed: Swiss-headquartered manufacturer of disposable and reusable auto-injectors (YpsoMate) and pen injectors for self-administration of biologics. Most direct competitor to E3D's Flexi-Q auto-injector family, serving the same pharma combination-product customers across disposable and reusable platforms.
• SHL Medical: Leading developer and manufacturer of auto-injectors and pen injectors (including the Molly platform) for pharmaceutical combination products. Competes directly with E3D across disposable auto-injector categories and has similar custom-platform B2B relationships with pharma.
• Owen Mumford: UK-headquartered specialist in auto-injectors (Aidaptus, AutoTouch) and pen injectors for self-administration. A focused direct competitor to E3D with comparable B2B pharma-combination-product GTM.
• Haselmeier: Developer and manufacturer of self-injection devices including pen injectors and auto-injector platforms for pharmaceutical partners. Comparable European-based mid-size peer with a similar customization-driven B2B model.
• LTS Lohmann Therapie-Systeme: German developer of transdermal therapeutic systems and wearable/needle-free drug delivery devices. Comparable B2B pharma partner model with overlap in wearable and patch-based subcutaneous delivery relevant to E3D's wearable injector portfolio.

Broad incumbents

• West Pharmaceutical Services: Global market leader in primary packaging and drug delivery, including the SmartDose wearable injector platform and auto-injector components. A broad incumbent offering containment, device, and analytics solutions that overlap with E3D's portfolio at the high end of pharma accounts.
• Becton Dickinson (BD) - Pharmaceutical Systems: Major manufacturer of prefillable syringes, auto-injectors, and wearable injectors (BD Intevia, BD Libertas) for large pharma combination products. Broad incumbent competing across both device and primary container categories relevant to E3D.
• Stevanato Group: Italian-based provider of drug containment solutions, prefillable syringes, and drug delivery devices including wearable injectors (Aidaptus auto-injector). Broad incumbent serving pharma customers across the device and container value chain, with overlapping B2B OEM model.
• Gerresheimer: Global manufacturer of pharmaceutical packaging and drug delivery devices, including auto-injectors and prefillable syringe systems. Broad incumbent with a wide portfolio that overlaps with E3D's PFS- and vial-based delivery platforms.

Emerging players

• Phillips-Medisize: Molex-owned contract developer of drug delivery devices including connected auto-injectors and wearable injectors for pharma. Comparable as an OEM/contract manufacturer of combination-product devices with growing capabilities in connected delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Customer concentration

• YouTubeyoutube.com/channel/UC5Df1F4Fx7-45vQ-R_5_3VA
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/e3d-elcam-drug-delivery-devices

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elcam Drug Delivery Devices